A Large Cohort Study of Genotype and Phenotype Correlations of Beta- Thalassemia in Iranian Population
- PMID: 26865931
- PMCID: PMC4748687
A Large Cohort Study of Genotype and Phenotype Correlations of Beta- Thalassemia in Iranian Population
Abstract
Background: Thalassemia syndromes are the most prevalent single gene disorders in Iran. This study aimed to evaluate the effect of different types of beta-globin gene mutations, co-inheritance of alpha-globin gene mutations and/or Xmn1 SNP on disease phenotype in a large cohort of Iranian patients.
Subjects and methods: In total, 433 patients were clinically classified into β-thalassemia major (TM) or intermedia (TI). Multiplex PCR, ARMS-PCR, RFLP-PCR and DNA sequencing were performed to identify both α- and β-globin gene mutations and Xmn1 polymorphism as well. All data were compared and analyzed by SPSS software in TM and TI groups, consequently.
Results: A total of 39 different β-globin mutations were identified. Among them, the most common were IVS IInt1 (40.33%) followed by IVS Int5 (9.56%), C30 (7.22%) and Fr8-9(7%). All patients were subjected to evaluate common α-globin gene deletions. The patients inherited concomitant mutations of α- and β-globin, showed no clinical modifications compared with those who had only β-globin mutation. The TI patients showed a significant increase in frequency of both heterozygous and homozygous form of the Xmn1 polymorphism. It was also found that β(0)/β(0) genotype patients, inherited the Xmn1 polymorphism required lesser blood transfusion.
Conclusion: No significant differences were observed, on the severity of disease, between patient's inherited defective α- and β-globin genes and ones with just β-globin gene mutation. Taking the results of this research into account, Xmn1 polymorphism can be considered as an important genetic factor modulating the severity of disease.
Keywords: Iran; Xmn1 polymorphism; α-thalassemia; β-thalassemia intermedia; β-thalassemia major.
Similar articles
-
Interaction of an α-Globin Gene Triplication with β-Globin Gene Mutations in Iranian Patients with β-Thalassemia Intermedia.Hemoglobin. 2015;39(3):201-6. doi: 10.3109/03630269.2015.1027914. Epub 2015 Jun 18. Hemoglobin. 2015. PMID: 26084319
-
Molecular study and genotype/phenotype correlation of β Thalassemia in Malaysia.Int J Lab Hematol. 2012 Aug;34(4):377-82. doi: 10.1111/j.1751-553X.2012.01405.x. Epub 2012 Feb 15. Int J Lab Hematol. 2012. PMID: 22335963
-
Molecular characterization of β-thalassemia intermedia in the West Bank, Palestine.BMC Hematol. 2019 Feb 18;19:4. doi: 10.1186/s12878-019-0135-6. eCollection 2019. BMC Hematol. 2019. PMID: 30820323 Free PMC article.
-
Hemoglobinopathies in India--clinical and laboratory aspects.Clin Lab Med. 2012 Jun;32(2):249-62. doi: 10.1016/j.cll.2012.04.011. Clin Lab Med. 2012. PMID: 22727003 Review.
-
Copy number variations of six and seven α-globin genes in a family with intermedia and major thalassemia phenotypes.Expert Rev Hematol. 2015 Oct;8(5):693-8. doi: 10.1586/17474086.2015.1075385. Epub 2015 Aug 6. Expert Rev Hematol. 2015. PMID: 26343893 Review.
Cited by
-
Haplotype Analysis in Carriers of β-Globin Gene Mutation Facilitates Genetic Counseling in β-Thalassemia: A Cross-Sectional Study in Kerman Province, Iran.Iran J Public Health. 2020 Apr;49(4):791-799. Iran J Public Health. 2020. PMID: 32548060 Free PMC article.
-
Clinical significance of mutational variants in beta and alpha genes in patients with hemoglobinopathies from two large Greek centers: a complex interplay between genotype and phenotype.J Mol Med (Berl). 2023 Sep;101(9):1073-1082. doi: 10.1007/s00109-023-02342-3. Epub 2023 Jul 7. J Mol Med (Berl). 2023. PMID: 37420139
-
β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint.Mediterr J Hematol Infect Dis. 2017 Feb 20;9(1):e2017018. doi: 10.4084/MJHID.2017.018. eCollection 2017. Mediterr J Hematol Infect Dis. 2017. PMID: 28293406 Free PMC article. Review.
-
The Effect of Xmn -1 Polymorphism and Coinheritance of Alpha Mutations on Age at First Blood Transfusion in Iranian Patients with Homozygote IVSI-5 Mutation.Int J Hematol Oncol Stem Cell Res. 2022 Jan 1;16(1):47-54. doi: 10.18502/ijhoscr.v16i1.8441. Int J Hematol Oncol Stem Cell Res. 2022. PMID: 35975115 Free PMC article.
-
Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β-Thalassemia.Biomolecules. 2021 May 18;11(5):755. doi: 10.3390/biom11050755. Biomolecules. 2021. PMID: 34070036 Free PMC article. Review.
References
-
- Chaisue C, Kitcharoen S, Wilairat P, et al. Alpha/beta-Globin mRNA ratio determination by multiplex quantitative real-time reverse transcription-polymerase chain reaction as an indicator of globin gene function. Clin Biochem. 2007 Dec;40(18):1373–7. - PubMed
-
- Weatherall D.J, Clegg J.B. The Thalassemia Syndromes. 4th ed. Vol. 486. Oxford: Malden/MA; Blackwell science; pp. 192–247.
-
- Fallah MS, Samavat A, Zeinali S. Iranian national program for the prevention of thalassemia and prenatal diagnosis: mandatory premarital screening and legal medical abortion. Prenat Diagn. 2009 Dec;29(13):1285–6. - PubMed
LinkOut - more resources
Full Text Sources